Has David Cha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,750 in general payments to David Cha, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Cha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Cha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Cha, MD

Transplant Surgery · Dallas, TXNPI 1871882209

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Intuitive Surgical at 55.6% of the total. 2024 is the largest year on record at $1,549, 5.6 times the $277 reported in 2019.

$2,750in general payments, 2019–2025

Across 24 payments — averaging $114.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$2K
GSK$240
Integra Lifesciences Corporation$153
AstraZeneca$140
Shire North American Group Inc$121
Takeda Pharmaceuticals U.S.A., Inc.$118
plus $448 from 9 others

What the payments were for

Food & beverage$1,25045%
Education$1,50055%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	2	$1,530
GSK	2	$240
Integra Lifesciences Corporation	1	$153
AstraZeneca	2	$140
Shire North American Group Inc	1	$121
Takeda Pharmaceuticals U.S.A., Inc.	1	$118
Veloxis Pharmaceuticals, Inc.	3	$109
Sanofi-aventis U.S. LLC	1	$97
Medtronic	2	$85
Sanara Medtech Inc.	4	$48
Lemaitre Vascular, Inc.	1	$29
Johnson & Johnson	1	$27
AbbVie	1	$22
Bard Peripheral Vascular, Inc.	1	$17
Heron Therapeutics, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,750 in reported general payments places this provider in the 55th percentile of 70 transplant surgery providers in Texas.

See all transplant surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$68,927

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in Dallas

Goran KlintmalmDallas$88K
Alejandro MejiaDallas$20K
Richard RuizDallas$16K
Christie GoodenDallas$8K
Steven HanishDallas$7K
Lori KautzmanDallas$7K
Jason SchwartzDallas$5K
Tiffany AnthonyDallas$5K
Anji WallDallas$4K
Gregory McKennaDallas$4K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →